Researchers at Karolinska Institutet in Sweden and Kyoto University in Japan have identified new subgroups of the blood ...
The Damon Runyon Cancer Research Foundation recently awarded two Fred Hutch postdoctoral fellows grants to support ...
Asianet Newsable on MSN
SLS stock snaps 2-day slide: Sellas’ SLS009 AML trial spotlights big pharma drug combo from ABBV, RHHBY and BMY
SLS009 traces back to Sellas’ 2022 GenFleet licensing deal, when the company obtained rights outside Greater China to GFH009, ...
A 1,563‑sample chromatin atlas reveals 16 epigenomic subgroups of AML, redefining disease classification, prognosis, and therapeutic vulnerabilities.
Early low-dose lenalidomide significantly reduces mutational burden without increasing AML risk in non-transfusion-dependent del(5q) MDS.
Medications for AML include chemotherapy and newer targeted therapies. With several options available, the right medication for you will depend on the specific characteristics of your cancer. Acute ...
Sellas Life Sciences stock faces downside risk ahead of REGAL Phase 3 data, and the valuation looks stretched. Click here to ...
Caitlin Leggett was diagnosed with acute myeloid leukemia for the second time in May 2026 ...
Warren Shen was diagnosed with acute myeloid leukemia in March ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results